Please try another search
For the nine months ended 30 September 2015, Tribute Pharmaceuticals Canada Inc revenues increased 84% to C$21M. Net loss increased from C$4.6M to C$12.4M. Revenues reflect Domestic segment increase of 82% to C$18.3M, International segment increase from C$1.3M to C$2.7M. Higher net loss reflects Change in warrant liability increase from C$163K to C$4M (expense), Selling, general and administrative increase of 46% to C$11.9M (expense).
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 9.01 | 6.43 | 5.59 | 5.47 |
Gross Profit | 5.65 | 4.1 | 3.56 | 3.47 |
Operating Income | -0.78 | -2.05 | -0.38 | 0.86 |
Net Income | 1.58 | -8.82 | -5.18 | -0.96 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 112.63 | 117.99 | 55.82 | 53.08 |
Total Liabilities | 63.82 | 72.09 | 26.43 | 22.74 |
Total Equity | 48.82 | 45.9 | 29.39 | 30.34 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -4.73 | -4.66 | -2.64 | -1.89 |
Cash From Investing Activities | -18.27 | -14.61 | -0.09 | -32.59 |
Cash From Financing Activities | 32.64 | 32.12 | 3.4 | 35.95 |
Net Change in Cash | 9.72 | 14.09 | 2.04 | 0.69 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review